+73.3%
PANW vs GSK
+31.2%
+42.0%
-36.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.4% | -1.9% | +2.3% | -0.1% |
| 7D | -10.3% | -1.8% | -8.5% | -10.7% |
| 30D | -8.1% | -2.2% | -5.9% | -8.5% |
| 3M | +19.3% | -1.8% | +21.2% | +19.0% |
| 6M | +110.2% | -10.6% | +120.8% | +107.3% |
| YTD | +80.9% | +4.4% | +76.5% | +77.1% |
| 1Y | +73.3% | +30.4% | +42.8% | +68.9% |
| All | +73.3% | +31.2% | +42.0% | +68.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling